Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03106337 · ClinicalTrials.gov registry record · NA
Diagnostic Accuracy of Shear-Wave Elastography for the Preoperative Risk Stratification of Follicular Lesions of the Thyroid
A NA study of Thyroid Nodule and Follicular Neoplasm, sponsored by Massachusetts General Hospital.
- Completed
- Registry status
- NA
- Development phase
- 35
- Enrollment target
- 1
- Study location
NCT03106337 is a NA study of Thyroid Nodule and Follicular Neoplasm that has completed, run by Massachusetts General Hospital. The registered enrollment target is 35 participants, below the 77-participant average among 5 other Thyroid Nodule trials with a reported enrollment target (55% lower). The trial reports 1 study location across 1 state.
The verdict
NCT03106337, a NA study of Thyroid Nodule and Follicular Neoplasm, has completed, sponsored by Massachusetts General Hospital.
- COMPLETED
- Registry status
- NA
- Development phase
- 35 participants
- Enrollment target
- 1
- Study location
Study Summary
As many as 70-85% subjects diagnosed with a follicular lesion on biopsy and undergoing surgery will have benign lesions verified by histopathology after surgery. Currently there is no method of pre-operatively diagnosing benign follicular lesions, as a result these subjects will have had surgery for diagnosis of a benign lesion. The aim of this study is to see whether shear-wave elastography, a new ultrasound technology can help pre-operatively diagnose benign follicular lesions. If successful, a lot of patients will not need surgery for the diagnosis of a benign lesion. The main goal of this study will be to evaluate the diagnostic accuracy of a new ultrasound technology, shear-wave elastography (SWE), for the diagnosis of malignancy in follicular lesions. Participants who have been diagnosed with a follicular lesion on thyroid biopsy and are scheduled for thyroid surgery will be eligible to participate. All participants will undergo a detailed ultrasound examination prior to their surgery. The results of the ultrasound will be compared with histopathology after surgery to test the diagnostic accuracy of SWE.
Conditions Studied
Interventions
- DEVICE Shear-Wave Elastography
Study Locations (1)
Massachusetts
- Massachusetts General Hospital - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 35 participants |
| Start Date | 2010-01 |
| Est. Completion | 2012-04 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03106337
The ClinicalTrials.gov registry entry for NCT03106337 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 35 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 77-participant average among 5 other Thyroid Nodule trials with a reported enrollment target (55% lower). The listed sponsor is Massachusetts General Hospital, which has 2,032 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Thyroid Nodule appearing as the primary indexed condition, and to 1 intervention - of which Shear-Wave Elastography is the first listed.
NCT03106337 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.
Frequently Asked Questions
What is clinical trial NCT03106337 about?
NCT03106337 is a clinical study titled "Diagnostic Accuracy of Shear-Wave Elastography for the Preoperative Risk Stratification of Follicular Lesions of the Thyroid". As many as 70-85% subjects diagnosed with a follicular lesion on biopsy and undergoing surgery will have benign lesions verified by histopathology after surgery. Currently there is no method of pre-operatively diagnosing benign follicular lesions, as a result these subjects will have had surgery fo...
What is the current status of trial NCT03106337?
This trial is currently completed. It is a NA study. The enrollment target is 35 participants. The study started on 2010-01. Estimated completion is 2012-04.
What conditions does trial NCT03106337 study?
This clinical trial studies the following conditions: Thyroid Nodule, Follicular Neoplasm.
What interventions are being tested in trial NCT03106337?
The interventions under investigation include: Shear-Wave Elastography (DEVICE).
Who is sponsoring clinical trial NCT03106337?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03106337 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Thyroid Nodule
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Radiofrequency Ablation Study in LatinX Patients
RECRUITING · NA
-
A Study of Multiparametric Ultrasound Imaging Methods
RECRUITING · NA
-
Prospective Evaluation of the Pulse Biosciences nPulse™ Vybrance™ Percutaneous Electrode System
RECRUITING · NA
-
TRAIL Study: Feasibility and Pilot
RECRUITING · NA
-
Decision Aid and Thyroid Nodules Management
RECRUITING · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.